We are delighted to announce that Pauli Wong, Partner at Eagle IP, has been invited to speak at the Entrepreneurship Series 2026, organized by the Hong Kong Life Sciences Society (HKLSS).

Pauli will lead an essential session titled "Protecting Innovation through IP and Legal Strategy," tailored specifically for the next generation of life sciences entrepreneurs, researchers, and biotech professionals. In an industry where intellectual property is often the most valuable asset a company owns, this seminar aims to equip participants with the strategic mindset needed to safeguard their scientific breakthroughs.

At Eagle IP, we are committed to empowering the local life sciences ecosystem. We are proud to partner with HKLSS in their mission to nurture talent and bridge the gap between academic excellence and commercial success in the life sciences sector.

我們過去活動

Recommended Insights

US vs CN: Foreign Filing License Requirements

2022年11月9日
In China, foreign filing requirements are generally very similar to the US — a foreign filing license is required if a foreign application is to be filed first for an invention made in the country. The Chinese equivalent to the US foreign filing license is called a confidentiality examination for foreign filing. According to Chinese […]

Updates on Hong Kong Patents Examination Guidelines in 2024

2024年2月29日
The Intellectual Property Department of the Government of the Hong Kong Special Administrative Region of the People’s Republic of China (HKIPD) has recently made several updates to the Hong Kong Patents Examination Guidelines, effective from 26 January, 2024. These changes mainly clarify and reflect the Registry’s current practices regarding patent examination for Standard Patent (R) […]

Foreigners Beware: China Proposes Requiring IP Made Using Exported Chinese Genetic Resources to be Co-Owned by Chinese Collaborators

2023年3月22日
Proposed Examination Guidelines for the New Chinese Patent Law – Topic 2: Genetic Resource Restriction How Will the Tightened Genetic Resource Restrictions Affect Your IP In 2019-2021, China’s Ministry of Science and Technology (“MOST”, or the Science Ministry) established several laws and regulations with respect to biosafety1 and human genetic resources management2 (collectively referred as […]

NMPA's Releases Draft Measures for Data Protection (Data Exclusivity)

2025年9月4日
In March 2025, China's National Medical Products Administration (NMPA) released yet another set of draft implementation measures on data protection.1 Key highlights of these new measures include the following: A Bit of History China's journey toward a comprehensive pharmaceutical data protection framework has been ongoing for over two decades, a roller coaster ride from its […]
Top crossarrow-right